Source: NBO (Translated)
Country defends the use of the drug in the early stages of the disease
With 2,420 confirmed cases, 87 deaths and 2,254 patients recovered until 07/12, Cuba has stood out in the fight against the pandemic of the new coronavirus. The Central American country has been using low doses of hydroxychloroquine to treat Covid-19 at an early stage.
The country’s residents have also followed the control measures established by the state health system.
We are aware of the controversies surrounding this product. Doctors here in general have a good opinion of the results achieved, as long as they are used early in low doses and only in patients without comorbidities, which can be complicated by hydroxychloroquine – said consultant to the president of BioCubaFarma, Augustin Lage Davila.
In addition to hydroxychloroquine, five other drugs are being used to treat the new coronavirus. Davila lists recombinant human interferon alfa-2b, which combines alpha interferon and gamma; biomodulin T; the CIGB-258 peptide and the humanized monoclonal antibody Itolizumab. Some of them were used to treat dengue and cancer.
BioCubaFarma is a Cuban organization in the biotechnology and pharmaceutical industries. Three medical brigades composed of 11 collaborators were sent from the country to work in Equatorial Guinea, São Tomé and Príncipe and Sierra Leone.
Related:
Cuba: Early hydroxychloroquine potent against COVID-19
Brazil: Early treatment with Covid Kit including HCQ is effective and safe, says MS doctor
Brazil’s President Jair Bolsonaro tests positive for COVID-19: Treated with hydroxychloroquine